CORINDUS VASCULAR ROBOTICS, INC
CVRS
CVRS was delisted on the 28th of October, 2019.
39 hedge funds and large institutions have $146M invested in CORINDUS VASCULAR ROBOTICS, INC in 2015 Q2 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$85.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$44M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.9M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$8.55M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.55M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFA
26
Nationwide Fund Advisors
Columbus,
Ohio
| $49K | +$59.7K | +13,992 | New |
|
|
AIG
27
American International Group
New York
| $46.3K | +$56.3K | +13,191 | New |
|
|
TC
28
TFS Capital
West Chester,
Pennsylvania
| $46K | +$56.5K | +13,236 | New |
|
|
BA
29
BlackRock Advisors
Wilmington,
Delaware
| $40K | +$48.5K | +11,369 | New |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $26K | +$31.6K | +7,407 | New |
|
|
SO
31
STRS Ohio
Columbus,
Ohio
| $25K | +$30.7K | +7,200 | New |
|
32
Bank of America
Charlotte,
North Carolina
| $16K | +$19.6K | +4,585 | New |
|
33
Morgan Stanley
New York
| $10K | +$11.9K | +2,789 | New |
|
34
UBS Group
Zurich,
Switzerland
| $6K | +$7.81K | +1,830 | New |
|
35
Citigroup
New York
| $5K | +$6.03K | +1,413 | New |
|
36
Wells Fargo
San Francisco,
California
| $4K | +$4.81K | +1,127 | New |
|
37
Invesco
Atlanta,
Georgia
| $4K | +$5.41K | +1,268 | New |
|
38
Barclays
London,
United Kingdom
| $1K | +$1.84K | +431 | New |
|
39
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$17 | +4 | New |
|
CVRS Hedge Fund Activity: Q2 2015 in Review
39 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q2 2015, worth a combined $146M.
Buyers outnumbered sellers: 39 funds opened new CVRS positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HealthCor Management, opening a new position worth an estimated $85.2M.
- 39 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $146M of CORINDUS VASCULAR ROBOTICS, INC stock for Q2 2015.
- 39 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q2 2015 and 0 closed out, a net change of +39 holders.
- The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q2 2015 was HealthCor Management, an estimated $85.2M added.
Based on aggregated 13F filings for Q2 2015.